June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Regulation of cell death by the pseudoprotease cFLIP
Author Affiliations & Notes
  • Kim Newton
    Genentech Inc, South San Francisco, California, United States
  • Footnotes
    Commercial Relationships   Kim Newton Genentech, Code E (Employment)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 1. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Kim Newton; Regulation of cell death by the pseudoprotease cFLIP. Invest. Ophthalmol. Vis. Sci. 2023;64(8):1.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Presentation Description : Death receptor Fas signals extrinsic apoptosis by promoting caspase-8 dimerization and activation. Impaired Fas signaling causes unconventional lymphocytes to accumulate, and elicits autoimmune lymphoproliferative syndrome (ALPS) in humans and lymphoproliferative (LPR) disease in mice. Although caspase-8 homodimer-deficient mice (for example, Casp8D387A/D387A mice) exhibit reduced Fas-induced apoptosis, they do not develop LPR disease. Therefore, there must be sufficient residual caspase-8 activity to suppress LPR disease. We now show that this lingering caspase-8 activity is provided by heterodimers of caspase-8 and the Cflar-encoded pseudoprotease cFLIPL. Thus, besides suppressing MLKL-dependent necroptosis, heterodimers of caspase-8 and cFLIPL can also mediate extrinsic apoptosis and suppress LPR disease. Consistent with caspase-8 cleavage of cFLIPL enhancing heterodimer proteolytic activity, knock-in mice expressing non-cleavable cFLIPL exhibited impaired extrinsic apoptosis and less TNF toxicity. Our data highlight a role for cFLIPL in promoting caspase-8 proteolytic activity and altering cell survival.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×